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The second edition of The Macrophage comes at a time of
resurgence of interest in innate immunity. The innate immune
system depends upon a range of effector cells with genetically
determined receptors recognising conserved molecular structures
expressed by a wide variety of potential invading organisms,
allowing it to distinguish between self and non-self. It thus differs
from the adaptive immune system comprising B and T lympho-
cytes, in that it does not rely upon clonal selection of effector cells
with unique antigen-specific receptors provided by rearrangement
of multiple gene segments. This means that the innate system is
capable of relatively rapid reactions, limited only by the time taken
for cytokine cascades to take effect. Foremost among the cell types
involved in the innate immune response are macrophages.
Macrophages have a range of important functions in relation to
inflammatory responses against foreign organisms, including
phagocytosis of smaller cells such as bacteria, direct or antibody-
directed killing of these and other organisms, and interaction with
the adaptive immune system particularly in the area of antigen
processing. With regard to cancer, macrophages form a significant
proportion of the total cell population in the vast majority of
tumour tissues and there is abundant evidence that under some
conditions, they are capable of cytotoxic or cytostatic activity
against malignant cells. However, there is a down side to all of this.
Macrophage activity can also be destructive to the host, as, for
example, its involvement in the development of atheromatous
plaques and rheumatoid arthritis, and in cancer macrophages very
often promote the survival and spread of tumour cells rather than
inhibit them, depending on the local cellular and cytokine
environment. This ambivalence was amply portrayed in the first
edition of The Macrophage and is an unchanging consequence of
the complex biology of macrophages. The complexity of tumour
biology and the heterogeneity of tumours in general only serve to
compound the problem for oncologists.
The second edition of The Macrophage is a well-presented
volume running to almost 650 pages. It contains 16 chapters by
acknowledged experts, and the topics range from macrophage
biology at both cellular and molecular levels, through interactions
with different target cells and organisms and the role of
macrophages in various pathological conditions in the host, to
mathematical models and gene therapy. The chapters perhaps
most likely to be of direct interest to oncologists are those entitled
The Biology of the Macrophage, Macrophages as Antigen-
Presenting Cells: Relationship to Dendritic Cells and Use in
Vaccination Studies, Macrophage–Virus Interactions, Macro-
phages in Tumour Biology and Macrophages in Gene Therapy:
Cellular Targets and Gene Delivery Vehicles. However, this is
certainly not to decry any of the other chapters in the book.
Covering every aspect of both pathological and normal functions
of macrophages as it does, this book provides a wealth of detailed
and up-to-date information relevant to anyone with more than a
passing interest in macrophages, immunology or cellular interac-
tions in general. A major feature repeated throughout the book is
the vast increase in knowledge of interactions between macro-
phages and other cell types, particularly those involving cytokine/
lymphokine interactions, and of associated cell signalling. Inter-
actions involved in the activation and regulation of macrophages
are still potentially confusing because of the multitude of factors
involved and often the multiplicity of effects of a given factor or
conversely their redundancy, but with further understanding they
could hold the key to managing the functions and activities of
macrophages in a more controlled way. Despite the rather
pessimistic caveat about macrophages in the above paragraph,
many of the authors have also highlighted other areas of promise
for the role of macrophages in the alleviation of a variety of
diseases, including cancer. Past attempts at cancer immunotherapy
by exploiting the activation of effector cells (predominantly
macrophages) by diverse natural or synthetic adjuvants were
mostly ineffectual, apart from isolated examples such as the
treatment of bladder cancer with BCG . However, there is now clear
hope of future treatments for many types of cancer based on the
use of macrophages and dendritic cells as antigen-presenting cells
to activate the adaptive immune response for active T-cell
immunotherapy and in some cases as prophylactic vaccines. There
is also great potential for gene therapy in which macrophages
could play a role as both targets for gene manipulation and as
vehicles for targeted delivery of recombinant genes to particular
tissues. These aspects offer promise for the treatment of many
other diseases besides cancer. These are areas that had not been
envisaged at the time of publication of the first edition of The
Macrophage, and are typical of the advances described in the
second edition. Overall, I consider the current edition of the book a
valuable addition to the literature; a must for all institutional
libraries and for laboratories or clinical departments actively
engaged in fields involving macrophages, cytokines or
immunology.
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